Addus HomeCare Co. (NASDAQ:ADUS) Receives $134.22 Consensus Target Price from Analysts

Shares of Addus HomeCare Co. (NASDAQ:ADUS - Get Free Report) have been assigned an average rating of "Buy" from the eleven research firms that are presently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, eight have given a buy rating and two have given a strong buy rating to the company. The average 1 year price objective among brokerages that have issued a report on the stock in the last year is $134.22.

ADUS has been the topic of a number of research analyst reports. Macquarie reaffirmed an "outperform" rating and set a $139.00 target price on shares of Addus HomeCare in a report on Monday, November 4th. JMP Securities assumed coverage on Addus HomeCare in a research note on Monday, December 16th. They set an "outperform" rating and a $150.00 price objective on the stock. Oppenheimer lifted their price objective on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an "outperform" rating in a report on Friday. StockNews.com raised shares of Addus HomeCare from a "hold" rating to a "buy" rating in a report on Friday. Finally, Citizens Jmp raised shares of Addus HomeCare to a "strong-buy" rating in a report on Monday, December 16th.

Insider Buying and Selling

In other news, EVP Roberton James Stevenson sold 2,250 shares of the stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the transaction, the executive vice president now directly owns 10,217 shares in the company, valued at $1,236,257. This trade represents a 18.05 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO R Dirk Allison sold 12,500 shares of the business's stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $123.16, for a total value of $1,539,500.00. Following the sale, the chief executive officer now directly owns 141,897 shares in the company, valued at approximately $17,476,034.52. The trade was a 8.10 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 39,750 shares of company stock valued at $4,930,750 in the last three months. 4.60% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Addus HomeCare

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Janney Montgomery Scott LLC raised its position in shares of Addus HomeCare by 0.9% during the fourth quarter. Janney Montgomery Scott LLC now owns 10,691 shares of the company's stock worth $1,340,000 after purchasing an additional 91 shares during the period. Inspire Investing LLC raised its holdings in Addus HomeCare by 3.3% during the 3rd quarter. Inspire Investing LLC now owns 3,111 shares of the company's stock worth $414,000 after buying an additional 100 shares during the period. New York State Teachers Retirement System lifted its stake in Addus HomeCare by 1.2% during the third quarter. New York State Teachers Retirement System now owns 8,510 shares of the company's stock valued at $1,132,000 after buying an additional 100 shares in the last quarter. Equitable Trust Co. boosted its holdings in shares of Addus HomeCare by 2.2% in the third quarter. Equitable Trust Co. now owns 4,825 shares of the company's stock worth $642,000 after buying an additional 106 shares during the period. Finally, Royce & Associates LP increased its position in shares of Addus HomeCare by 1.2% in the third quarter. Royce & Associates LP now owns 8,924 shares of the company's stock worth $1,187,000 after acquiring an additional 109 shares in the last quarter. 95.35% of the stock is owned by institutional investors and hedge funds.

Addus HomeCare Stock Performance

Shares of ADUS stock traded up $3.51 during mid-day trading on Friday, reaching $130.62. 132,235 shares of the company were exchanged, compared to its average volume of 103,123. The business's 50 day simple moving average is $126.10 and its 200 day simple moving average is $127.03. The company has a market capitalization of $2.37 billion, a P/E ratio of 29.89, a P/E/G ratio of 1.73 and a beta of 1.00. Addus HomeCare has a fifty-two week low of $85.94 and a fifty-two week high of $136.72.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, topping the consensus estimate of $1.28 by $0.02. The company had revenue of $289.80 million during the quarter, compared to the consensus estimate of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The company's revenue was up 7.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.03 EPS. On average, analysts forecast that Addus HomeCare will post 4.58 EPS for the current year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.